Michael Dobelbower
Overview
Explore the profile of Michael Dobelbower including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
1375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Veale C, Hablitz D, Krontiras H, Dalton A, Meyers K, et al.
Front Oncol
. 2022 Jul;
12:901312.
PMID: 35880164
Background: For appropriately selected patients with early-stage breast cancer (ESBC), accelerated partial breast irradiation (APBI) yields equivalent rates of ipsilateral breast tumor recurrence with mixed results in patient-rated cosmesis compared...
2.
Patel M, Colvin T, Kirkland R, Marcrom S, Dobelbower M, Spencer S, et al.
Cureus
. 2020 Jul;
12(6):e8618.
PMID: 32676253
Purpose Our study reports the clinical outcomes of patients treated with 5-mm isotropic margin, fiducial-guided stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC). We also...
3.
Ettinger D, Wood D, Aggarwal C, Aisner D, Akerley W, Bauman J, et al.
J Natl Compr Canc Netw
. 2019 Dec;
17(12):1464-1472.
PMID: 31805526
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update,...
4.
Ettinger D, Aisner D, Wood D, Akerley W, Bauman J, Chang J, et al.
J Natl Compr Canc Netw
. 2018 Jul;
16(7):807-821.
PMID: 30006423
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy...
5.
Ettinger D, Wood D, Aisner D, Akerley W, Bauman J, Chirieac L, et al.
J Natl Compr Canc Netw
. 2017 Apr;
15(4):504-535.
PMID: 28404761
This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease....
6.
Ettinger D, Wood D, Akerley W, Bazhenova L, Borghaei H, Camidge D, et al.
J Natl Compr Canc Netw
. 2016 Jul;
14(7):825-36.
PMID: 27407123
These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Malignant Pleural Mesothelioma (MPM). These NCCN Guidelines Insights discuss systemic therapy regimens and surgical controversies for MPM....
7.
Dulaney C, Barrett O, Rais-Bahrami S, Wakefield D, Fiveash J, Dobelbower M
Cureus
. 2016 May;
8(4):e580.
PMID: 27226941
Introduction: Cancer center websites are trusted sources of internet information about treatment options for prostate cancer. The quality of information on these websites is unknown. The objective of this study...
8.
Rosenthal S, Hunt D, Sartor A, Pienta K, Gomella L, Grignon D, et al.
Int J Radiat Oncol Biol Phys
. 2015 Jul;
93(2):294-302.
PMID: 26209502
Purpose: Long-term (LT) androgen suppression (AS) with radiation therapy (RT) is a standard treatment of high-risk, localized prostate cancer (PCa). Radiation Therapy Oncology Group 9902 was a randomized trial testing...